Association of epidermal growth factor receptor (EGFR) gene copy number amplification with neck lymph node metastasis in areca-associated oral carcinomas

Oral Oncology

Volumn 44, Issue 3, 2008, Pages 270-276

  Chiang, Wei Fan ^a,c   Liu, Shyun Yeu ^a   Yen, Ching Yu ^a   Lin, Chin Nan ^a   Chen, Yen Chia ^b,c   Lin, Shu Chun ^c   Chang, Kuo Wei ^c  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Amplification; EGFR; Oral cancer

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; ARTICLE; CANCER PATIENT; CANCER STAGING; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; NECK METASTASIS; ORAL SQUAMOUS CELL CARCINOMA; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOMATIC MUTATION; STATISTICAL SIGNIFICANCE;

ADULT; ARECA; CARCINOGENS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; GENE AMPLIFICATION; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, ERBB-1; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS;

EID: 39149095593     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2007.02.008     Document Type: Article

References (27)

1. Chiang W.F., Yen C.Y., Lin C.N., Liaw G.A., Chiu C.T., Hsia Y.J., et al. Up-regulation of a serine-threonine kinase proto-oncogene Pim-1 in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 35 (2006) 740-745
2. Lo H.W., and Hung M.C. Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival. Br J Cancer 94 (2006) 184-188
3. Yarden Y. The EGFR family and its ligands in human cancer: signalling mechanisms and therapeutic opportunities. Eur J Cancer 37 Suppl. 4 (2001) S3-S8
4. Shigematsu H., Lin L., Takahashi T., Nomura M., Suzuki M., Wistuba II, et al. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 97 (2005) 339-346
5. Giaccone G., and Rodriguez J.A. EGFR inhibitors: what have we learned from the treatment of lung cancer?. Nat Clin Pract Oncol 2 (2005) 554-561
6. Lynch T.J., Bell D.W., Sordella R., Gurubhagavatula S., Okimoto R.A., Brannigan B.W., et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350 (2004) 2129-2139
7. Hougardy B.M., Maduro J.H., van der Zee A.G., Willemse P.H., de Jong S., and de Vries E.G. Clinical potential of inhibitors of survival pathways and activators of apoptotic pathways in treatment of cervical cancer: changing the apoptotic balance. Lancet Oncol 6 (2005) 589-598
8. Kalyankrishna S., and Grandis J.R. Epidermal growth factor receptor biology in head and neck cancer. J Clin Oncol 24 (2006) 2666-2672
9. Chung C.H., Ely K., McGavran L., Varella-Garcia M., Parker J., Parker N., et al. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas. J Clin Oncol 24 (2006) 4170-4176
10. Kalish L.H., Kwong R.A., Cole I.E., Gallagher R.M., Sutherland R.L., and Musgrove E.A. Deregulated cyclin D1 expression is associated with decreased efficacy of the selective epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in head and neck squamous cell carcinoma cell lines. Clin Cancer Res 10 (2004) 7764-7774
11. Leong P.L., Andrews G.A., Johnson D.E., Dyer K.F., Xi S., Mai J.C., et al. Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth. Proc Natl Acad Sci USA 100 (2003) 4138-4143
12. Lo H.W., Hsu S.C., Ali-Seyed M., Gunduz M., Xia W., Wei Y., et al. Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway. Cancer Cell 7 (2005) 575-589
13. Psyrri A., Yu Z., Weinberger P.M., Sasaki C., Haffty B., Camp R., et al. Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis. Clin Cancer Res 11 (2005) 5856-5862
14. Huang S.F., Liu H.P., Li L.H., Ku Y.C., Fu Y.N., Tsai H.Y., et al. High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan. Clin Cancer Res 10 (2004) 8195-8203
15. Lee J.W., Soung Y.H., Kim S.Y., Nam H.K., Park W.S., Nam S.W., et al. Somatic mutations of EGFR gene in squamous cell carcinoma of the head and neck. Clin Cancer Res 11 (2005) 2879-2882
16. Loeffler-Ragg J., Witsch-Baumgartner M., Tzankov A., Hilbe W., Schwentner I., Sprinzl G.M., et al. Low incidence of mutations in EGFR kinase domain in Caucasian patients with head and neck squamous cell carcinoma. Eur J Cancer 42 (2006) 109-111
17. Schwartz J.L., Muscat J.E., Baker V., Larios E., Stephenson G.D., Guo W., et al. Oral cytology assessment by flow cytometry of DNA adducts, aneuploidy, proliferation and apoptosis shows differences between smokers and non-smokers. Oral Oncol 39 (2003) 842-854
18. Lin S.C., Liu C.J., Ko S.Y., Chang H.C., Liu T.Y., and Chang K.W. Copy number amplification of 3q26-27 oncogenes in microdissected oral squamous cell carcinoma and oral brushed samples from areca chewers. J Pathol 206 (2005) 417-422
19. Erjala K., Sundvall M., Junttila T.T., Zhang N., Savisalo M., Mali P., et al. Signaling via ErbB2 and ErbB3 associates with resistance and epidermal growth factor receptor (EGFR) amplification with sensitivity to EGFR inhibitor gefitinib in head and neck squamous cell carcinoma cells. Clin Cancer Res 12 (2006) 4103-4111
20. Chen Y.J., Lin S.C., Kao T., Chang C.S., Hong P.S., Shieh T.M., et al. Genome-wide profiling of oral squamous cell carcinoma. J Pathol 204 (2004) 326-332
21. Nagatsuka H., Ishiwari Y., Tsujigiwa H., Nakano K., and Nagai N. Quantitation of epidermal growth factor receptor gene amplification by competitive polymerase chain reaction in pre-malignant and malignant oral epithelial lesions. Oral Oncol 37 (2001) 599-604
22. Cohen E.E., Lingen M.W., Martin L.E., Harris P.L., Brannigan B.W., Haserlat S.M., et al. Response of some head and neck cancers to epidermal growth factor receptor tyrosine kinase inhibitors may be linked to mutation of ERBB2 rather than EGFR. Clin Cancer Res 11 (2005) 8105-8108
23. Mrhalova M., Plzak J., Betka J., and Kodet R. Epidermal growth factor receptor - its expression and copy numbers of EGFR gene in patients with head and neck squamous cell carcinomas. Neoplasma 52 (2005) 338-343
24. Laimer K., Spizzo G., Gastl G., Obrist P., Brunhuber T., Fong D., et al. High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: a TMA-based immunohistochemical analysis. Oral Oncol 43 (2007) 193-198
25. Cohen E.E., Rosen F., Stadler W.M., Recant W., Stenson K., Huo D., et al. Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck. J Clin Oncol 21 (2003) 1980-1987
26. Sonnweber B., Dlaska M., Skvortsov S., Dirnhofer S., Schmid T., and Hilbe W. High predictive value of epidermal growth factor receptor phosphorylation but not of EGFRvIII mutation in resected stage I non-small cell lung cancer (NSCLC). J Clin Pathol 59 (2006) 255-259
27. Eley G.D., Reiter J.L., Pandita A., Park S., Jenkins R.B., Maihle N.J., et al. A chromosomal region 7p11.2 transcript map: its development and application to the study of EGFR amplicons in glioblastoma. Neuro-oncol 4 (2002) 86-94